Published in Infect Immun on September 10, 2012
Large-scale genomic sequencing of extraintestinal pathogenic Escherichia coli strains. Genome Res (2014) 1.20
Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun (2013) 0.93
Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. J Immunol (2014) 0.91
Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs. Appl Environ Microbiol (2014) 0.89
Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With Urosepsis. Open Forum Infect Dis (2015) 0.85
Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection. Infect Immun (2015) 0.84
Development of a Vaccine against Escherichia coli Urinary Tract Infections. Pathogens (2015) 0.84
Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Metallomics (2015) 0.83
Measuring Escherichia coli Gene Expression during Human Urinary Tract Infections. Pathogens (2016) 0.82
A conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility. Infect Immun (2014) 0.78
Signature-tagged mutagenesis and co-infection studies demonstrate the importance of P fimbriae in a murine model of urinary tract infection. Pathog Dis (2015) 0.77
Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli. J Bacteriol (2016) 0.77
The high prevalence of serine protease autotransporters of Enterobacteriaceae (SPATEs) in Escherichia coli causing neonatal septicemia. Eur J Clin Microbiol Infect Dis (2014) 0.76
Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence. Infect Genet Evol (2015) 0.76
Cooperation of Adhesin Alleles in Salmonella-Host Tropism. mSphere (2017) 0.75
Genomic Microbial Epidemiology Is Needed to Comprehend the Global Problem of Antibiotic Resistance and to Improve Pathogen Diagnosis. Front Microbiol (2016) 0.75
The Yersiniabactin-Associated ATP Binding Cassette Proteins YbtP and YbtQ Enhance Escherichia coli Fitness during High-Titer Cystitis. Infect Immun (2016) 0.75
Genetic Attributes of E. coli Isolates from Chlorinated Drinking Water. PLoS One (2017) 0.75
Virulence Markers and Phylogenetic Analysis of Escherichia coli Strains with Hybrid EAEC/UPEC Genotypes Recovered from Sporadic Cases of Extraintestinal Infections. Front Microbiol (2017) 0.75
Regulation of Expression of Uropathogenic Escherichia coli Nonfimbrial Adhesin TosA by PapB Homolog TosR in Conjunction with H-NS and Lrp. Infect Immun (2016) 0.75
Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H30-Rx, H22 and H41 subclones. Sci Rep (2017) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
Standard reference strains of Escherichia coli from natural populations. J Bacteriol (1984) 11.16
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis (2000) 8.85
The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun (1999) 6.41
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis (1982) 4.37
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon (2003) 3.54
Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis (2000) 3.35
Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections. Prog Allergy (1983) 3.12
A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med (2000) 2.81
Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children. J Infect Dis (1997) 2.78
TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect Immun (2001) 2.66
Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother (2003) 2.51
Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14
Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol (2008) 2.02
Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity. Mol Microbiol (1993) 1.93
Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis (2006) 1.92
What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol (2011) 1.83
Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis (2007) 1.73
Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol (1987) 1.66
Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60
Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. J Infect Dis (1991) 1.57
Molecular detection and identification of intimin alleles in pathogenic Escherichia coli by multiplex PCR. J Clin Microbiol (1999) 1.56
Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis (2004) 1.56
Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J Clin Microbiol (2008) 1.54
Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44
Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl Environ Microbiol (2007) 1.43
Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun (2011) 1.41
Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect Immun (2004) 1.36
Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins. Proc Natl Acad Sci U S A (2011) 1.31
Escherichia coli K-12 possesses multiple cryptic but functional chaperone-usher fimbriae with distinct surface specificities. Environ Microbiol (2010) 1.28
Adherence of enterohemorrhagic Escherichia coli strains to a human colonic epithelial cell line (T84). Infect Immun (1992) 1.21
Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members. J Clin Microbiol (2008) 1.15
Genomic comparison of Escherichia coli K1 strains isolated from the cerebrospinal fluid of patients with meningitis. Infect Immun (2006) 1.12
A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev Infect Dis (1983) 1.11
Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio (2011) 1.04
Virulence factors predict Escherichia coli colonization patterns among human and animal household members. Ann Intern Med (2004) 0.99
Distribution of the serine protease autotransporters of the Enterobacteriaceae among extraintestinal clinical isolates of Escherichia coli. J Clin Microbiol (2005) 0.94
Secretor state and renal scarring in girls with recurrent pyelonephritis. FEMS Microbiol Immunol (1989) 0.87
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (2011) 12.29
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother (2007) 7.81
Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis (2005) 6.85
Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci U S A (2006) 5.13
Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect (2003) 4.63
Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med (2013) 4.62
Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med (2013) 4.55
Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med (2004) 4.30
The iPlant Collaborative: Cyberinfrastructure for Plant Biology. Front Plant Sci (2011) 4.16
The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol (2007) 3.55
Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med (2007) 3.54
Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28
Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis (2007) 3.12
Natural genetic variation in lycopene epsilon cyclase tapped for maize biofortification. Science (2008) 3.06
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis (2013) 2.85
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio (2013) 2.64
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology (2011) 2.51
Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol (2007) 2.50
Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis (2002) 2.48
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47
Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr (2009) 2.47
Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis (2004) 2.40
Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology (2005) 2.40
Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl Environ Microbiol (2007) 2.22
Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol (2012) 2.22
Genome sequencing of environmental Escherichia coli expands understanding of the ecology and speciation of the model bacterial species. Proc Natl Acad Sci U S A (2011) 2.21
Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev (2009) 2.20
Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest (2003) 2.16
Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14
Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun (2006) 2.11
DNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli strains. J Bacteriol (2006) 2.11
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08
Urologic complications of diabetes. Diabetes Care (2005) 2.03
Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol (2008) 2.02
Characterizing the APEC pathotype. Vet Res (2005) 2.01
High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol (2012) 2.00
Complications of Foley catheters--is infection the greatest risk? J Urol (2012) 2.00
Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun (2004) 1.99
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis (2011) 1.94
Expansion of the IncX plasmid family for improved identification and typing of novel plasmids in drug-resistant Enterobacteriaceae. Plasmid (2012) 1.94
Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc (2006) 1.93
A two-way messaging system to enhance antiretroviral adherence. J Am Med Inform Assoc (2003) 1.89
Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med (2013) 1.88
Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog (2009) 1.83
Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol (2006) 1.82
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun (2005) 1.80
Complete DNA sequence of a ColBM plasmid from avian pathogenic Escherichia coli suggests that it evolved from closely related ColV virulence plasmids. J Bacteriol (2006) 1.79
Reduction of inappropriate urinary catheter use at a Veterans Affairs hospital through a multifaceted quality improvement project. Clin Infect Dis (2011) 1.79
Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun (2004) 1.76
Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med (2007) 1.73
Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol (2013) 1.72
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun (2010) 1.72
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med (2009) 1.72
Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis (2012) 1.69
The siderophore yersiniabactin binds copper to protect pathogens during infection. Nat Chem Biol (2012) 1.68
Complete DNA sequence, comparative genomics, and prevalence of an IncHI2 plasmid occurring among extraintestinal pathogenic Escherichia coli isolates. Antimicrob Agents Chemother (2006) 1.68
Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog (2009) 1.67
Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest (2010) 1.67
The genetic structure of Escherichia coli populations in primary and secondary habitats. Microbiology (2002) 1.67
Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol (2011) 1.66
Food-borne origins of Escherichia coli causing extraintestinal infections. Clin Infect Dis (2012) 1.65
Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65
Asymptomatic bacteriuria in adults. Am Fam Physician (2006) 1.62
Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol (2004) 1.62
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis (2010) 1.60
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60
Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med (2005) 1.59
Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.59
Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol (2004) 1.59
IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun (2002) 1.59
Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infect Immun (2010) 1.58
ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections. J Infect Dis (2002) 1.57
Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun (2002) 1.56
Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis (2004) 1.56
Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort. Clin Infect Dis (2003) 1.56
Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun (2002) 1.56
Loop-mediated isothermal amplification assay for rapid detection of common strains of Escherichia coli. J Clin Microbiol (2008) 1.55
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol (2010) 1.55
Multilocus sequence typing lacks the discriminatory ability of pulsed-field gel electrophoresis for typing Salmonella enterica serovar Typhimurium. J Clin Microbiol (2005) 1.54
Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J Clin Microbiol (2008) 1.54
Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system. J Biol Chem (2002) 1.54
Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. JAMA (2012) 1.54
Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician (2011) 1.51
Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun (2007) 1.50
Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology (2013) 1.49
Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun (2006) 1.49
Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2005) 1.49
Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol (2008) 1.49
The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun (2005) 1.49
Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One (2009) 1.49
Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol (2012) 1.48